UTHSC sickle cell researcher on ground floor in latest FDA approvals

By , Daily Memphian Updated: December 16, 2019 4:10 PM CT | Published: December 16, 2019 4:05 AM CT

For years sickle cell has been treated simply with pain medicine, but new research breakthroughs are producing therapies that can really attack the disease and improve lives.


Kenneth Ataga sickle cell UTHSC
Jane Roberts

Jane Roberts

Longtime journalist Jane Roberts is a Minnesotan by birth and a Memphian by choice. She's lived and reported in the city more than two decades. She covers business news and features for The Daily Memphian.


Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here